1.
Kumar AH, George M. Evaluating the Chrono-pharmacology of Icosapent Ethyl to Assess its Therapeutic Efficacy in Reducing Hypertriglyceridemia Associated Cardiovascular Events. BEMS Reports [Internet]. 2021Feb.16 [cited 2022May17];5(2):26-8. Available from: https://bemsreports.org/index.php/bems/article/view/54